Home / Central Data Catalog / FRESH-83175-EN
central

Evaluation of the Efficacy of an Early Cardiac Rehabilitation Protocol in Patients After a Myocardial Infarction

Australia, Austria, 2026 - 2027
Reference ID
FReSH-83175-en
Producer(s)
Camille;HUNSINGER, PHARM;10, Respsi;8
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Sep 08, 2026
Last modified
Sep 11, 2026
Page views
7
  • Identification
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Quality standards
  • Access policy
  • Data Access
  • Contacts
  • Metadata production

    • Identification

    Survey ID number

    FReSH-83175-en
    Title

    Evaluation of the Efficacy of an Early Cardiac Rehabilitation Protocol in Patients After a Myocardial Infarction
    Abbreviation or Acronym

    Acronym of the study
    Country
    Name Country code
    Australia au
    Austria at
    Abstract

    This study aims to evaluate the impact of an early-onset cardiac rehabilitation program (within 7 days of the event) on functional recovery and quality of life in patients who have suffered a myocardial infarction. The study compares a group receiving the early intervention protocol to a group following the standard care pathway, with follow-up at 3, 6, and 12 months to assess exercise capacity, rehospitalization rates, and adherence to medication.
    Kind of Data

    ['Other']
    Unit of Analysis

    Individus

    Coverage

    Universe

    {
    "level_sex_clusion_I": [
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D005260"
    },
    "value": "Female"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D008297"
    },
    "value": "Male"
    }
    ],
    "level_age_clusion_I": [
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D055815"
    },
    "value": "Young Adult (19 to 24 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D000328"
    },
    "value": "Adult (25 to 44 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D008875"
    },
    "value": "Middle Aged (45 to 64 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D000368"
    },
    "value": "Aged (65 to 79 years)"
    }
    ],
    "level_type_clusion_I": "General population",
    "level_type_clusion_other": "",
    "clusion_I": "Inclusion Criteria\r\n",
    "clusion_E": "Exclusion Criteria\r\n"
    }

    Producers and sponsors

    Primary investigators
    Name
    Camille;HUNSINGER
    PHARM;10
    Respsi;8
    Producers
    Name Role
    ABBOTT FRANCE sponsor
    Funding Agency/Sponsor
    Name
    ABBVIE
    ABBOTT FRANCE
    Other Identifications/Acknowledgments
    Name
    ;

    Study authorization

    Agency
    Agency name
    ANSM
    CNIL
    CPP

    Sampling

    Sample frame

    Unit Type

    ['Other']
    Sampling Procedure

    ['{"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Terms and Conditions for the Provision of Aggregated Data
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2026-09-08 2027-10-08
    Frequency of Data Collection

    Collection Frequency *
    Mode of data collection
    • {"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Primary Outcome *
    Type
    secondary evaluation
    Description
    Secondary evaluation (assessment) criterion(s)

    Quality standards

    Quality standards
    Standard
    ['Standard(s) or bill(s) of materials used']
    Other quality statement

    ['Quality procedure used']

    Access policy

    Location of Data Collection

    Data Location
    Completeness of Study Stored

    Completeness of Data Files

    Data Access

    Access authority
    Name Email
    FIrst name;LASTNAME pharm10@impact-dev.tn
    Confidentiality
    Confidentiality declaration text
    Non-disclosure agreement
    Access conditions

    Terms of Access to Data
    Citation requirements

    Citation Requirement
    Deposit requirements

    Requirement to Submit Work
    Availability Status

    {"extLink":{"title":"COAR","uri":"http://purl.org/coar/access_right/c_abf2"},"value":"Open access"}
    Special Permissions
    Indicate if special permissions are required to access a resource
    No
    Restrictions

    Access Restrictions

    Contacts

    Contacts
    Name Email
    Tohmas;Martin med8@impact-dev.tn
    Prenom;NOM pharm10@impactd-dev.tn
    Camille;HUNSINGER contact@impactgroup.tech

    Metadata production

    DDI Document ID

    FReSH-83175-en
    Producers
    Name
    Mohamed Lajimi
    Back to Catalog